Editor's Pick

Sociologist and author Andrew Scull discusses the history of psychiatry's "Desperate Remedies," from lobotomy and the asylum to the failures of today's drugs and the fads of ketamine and deep brain stimulation.

Laura Van Tosh has been a leader in psychiatric survivor circles for 40 years, working at local, state and national levels.

Our guest today is Jessica Taylor, author of Sexy But Psycho: How the Patriarchy Uses Women’s Trauma Against Them, which was published in March...

A dialogue between Jim Phelps and Robert Whitaker about Nassir Ghaemi's latest article, which concluded that psychiatric drugs, except for lithium, do not provide a long-term benefit.

Nassir Ghaemi: “Most psychiatric medications are purely symptomatic, with no known or proven effect on the underlying disease. They are like 50 variations of aspirin, used for fever or headache, rather than drugs that treat the causes of fever or headache.”

Despite the well-documented greater effectiveness of behavior therapy, psychiatry's choice of treatment for mental disorder heavily favors drugs.

Tara Thiagarajan is founder and chief scientist of Sapien Labs, a nonprofit organization that runs the Mental Health Million Project, we discuss its annual Mental State of the World Report, which uses an online survey to track mental wellbeing among internet-enabled populations around the world.

Bergner’s piece in The New York Times challenged the illusions of psychiatry. That made some people angry, outraged, or scared. The result is their comments section.

Risk of depression increased when children were taking methylphenidate for ADHD, but once they stopped taking the drug, depression risk dropped to normal levels.

God supported me during my psychosis. I was afraid that I would lose God when I took antipsychotics again. That had happened after my first forced medication.

A dialogue between Dr. Jim Phelps—a psychiatrist who questions whether MIA is doing more harm than good by reporting the results of long-term trials of psychiatric drugs—and Robert Whitaker, founder of MIA.

In his new book, former NIMH director Thomas Insel, while exploring the causes of poor mental health outcomes in the United States, omits any mention of NIMH studies that tell of how the drugs worsen long-term outcomes.

Stories of a state hospital leader who challenged the mental health system by placing patients as the most important people: Dr. Dean K. Brooks of Oregon State Hospital.

Reviews of four recent books reflecting various perspectives on the mental health system.

Hospitalized COVID patients over 65 were three times as likely to receive a dementia diagnosis if they took psychiatric drugs.

"You're not going to sell many drugs by saying your problem is your life experiences. It's far more effective to say your problem is in the brain. It's an imbalance, we can correct that imbalance, just take our product."

Sera Davidow is a filmmaker, activist, advocate, author, and mother of two very busy kids. As a survivor of physical, sexual, and emotional abuse...

Thomas Jobe was a collaborator in a longitudinal study that upended conventional thinking about antipsychotics. He died March 16.

Withholding antipsychotics may be beneficial for memory, the researchers write.

Ads pushing transcranial magnetic stimulation are everywhere. As someone harmed by the treatment, I believe they are misleading and unethical.

The prescribing of stimulants to preschoolers diagnosed with ADHD is on the rise, which is said to be an "evidence-based" practice. A review of that "evidence base" reveals that claims that ADHD is characterized by genetic and brain abnormalities are belied by the data, and that the NIMH trial of methylphenidate in this age group told of long-term harm.

MIA’s Ayurdhi Dhar interviews Dana Becker about how therapeutic culture fails to adequately address women’s suffering.

Life in the DC was far too complicated for me to be able to just listen to my body and sleep on a thick yoga mat placed on the floor to alleviate my severe back pain.

We talk with Dr. Michael Hengartner about his new book which addresses the overprescribing of antidepressant drugs and critically examines the scientific evidence on their efficacy and safety.

Even after their own advisory committee criticized call tracing, leaders of the National Suicide Prevention Lifeline have been lobbying government for cutting-edge mass surveillance and tracking technology. Privacy experts are raising concerns.